Natural Compounds That Activate the KEAP1/Nrf2 Signaling Pathway as Potential New Drugs in the Treatment of Idiopathic Parkinson's Disease
Recently, a single-neuron degeneration model has been proposed to understand the development of idiopathic Parkinson's disease based on (i) the extremely slow development of the degenerative process before the onset of motor symptoms and during the progression of the disease and (ii) the fact t...
Saved in:
Main Authors: | Sandro Huenchuguala (Author), Juan Segura-Aguilar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Keap1/Nrf2 Signaling Pathway
by: Gerasimos P. Sykiotis
Published: (2021) -
A Preclinical Model for Parkinson's Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies
by: Juan Segura-Aguilar, et al.
Published: (2023) -
The KEAP1/NRF2 Signaling Pathway in Keratinization
by: Yosuke Ishitsuka, et al.
Published: (2020) -
Natural and synthetic compounds in Ovarian Cancer: A focus on NRF2/KEAP1 pathway
by: Giovanni Tossetta, et al.
Published: (2022) -
The Keap1/Nrf2 Signaling Pathway in the Thyroid-2020 Update
by: Christina Thanas, et al.
Published: (2020)